Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diluted Insulin in Young Children
NCT03666065Phase 1Completed
- Sponsor
- Yale University
- Start
- Jan 2020
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of insulin aspart in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Yale University. Primary endpoint: Maximum Insulin Concentration at 240 minutes. Started Jan 2020; status: completed.
02
Drugs
insulin aspart
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03666065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666065.